Analysis of Eye Tissue
Eye Disease, Inflammation, Uveitis
About this trial
This is an observational trial for Eye Disease focused on measuring Ocular Inflammatory Disease, Cataracts, Vitrectomy, Extracapsular, Cataract Surgery, Uveitis, Lenticular Opacity, Vitreal Opacity
Eligibility Criteria
Patients of either sex will be admitted to this study. All patients should have a previous history of uveitis. The patient must have lenticular or vitreal opacities which are significantly impairing their vision and for which surgical removal of the opacity has a reasonable chance of improving the vision. Patients should have vision of 20/80 or worse. Patients may have any of the following syndromes: anterior uveitis, including HLA-B27-associated iritis and juvenile rheumatoid arthritis, ocular sarcoid, intermediate uveitis and pars planitis, birdshot retinochoroidopathy, Behcet's disease, Vogt-Koyanagi-Harada's syndrome, sympathic ophthalmia and idiopathic posterior uveitis.
Sites / Locations
- National Eye Institute (NEI)